Epinephrine Bitartrate, Lidocaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Epinephrine Bitartrate, Lidocaine Hydrochloride Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 02/22/2012. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-3178-02
- Dosage Form
- Injection
- Presentation
- Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)
- Initial Posting
- 02/22/2012
- Revised Date
Reason
Other